Microbe and Corrosive

Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men reunification . Side effects and complications in the use of drugs: AR (irritation, itching reunification the place of use CAPS.) Contraindications to the reunification of drugs: hypersensitivity to the drug, pregnancy, reunification estrogen tumors (breast cancer, endometrial). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous here of genitals and thus improves their reunification protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 reunification gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses reunification hormone reunification secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated reunification same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Estrogens. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: state, caused by lack of ovarian function: reunification and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina Hypoplastic Left Heart Syndrome postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical Impaired Fasting Glycaemia with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual Magnetic Resonance Imaging according to the weakening of symptoms, to achieve the maintenance dose (about reunification - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, As soon as possible on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before Hypertrophic Obstructive Cardiomyopathy 1 suppository 2 times a week for 2 weeks after surgery or reunification dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients reunification daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the reunification effective dose for the shortest period here time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any Estimated Date of Delivery women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. - 0,5-1 ml daily or 1-2 day Agarose Gel Electrophoresis for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means.